LUXNA BIOTECH
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
LUXNA BIOTECH
Industry:
Biotechnology Health Care Product Research
Founded:
2017-12-18
Address:
Osaka, Osaka, Japan
Country:
Japan
Website Url:
http://www.luxnabiotech.co.jp
Total Employee:
1+
Status:
Active
Contact:
066-170-1228
Total Funding:
880 M JPY
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Employees Featured
Hideaki Sato Chief Executive Officer & President @ Luxna Biotech
Chief Executive Officer & President
Founder
Investors List
Summit Pharmaceuticals International
Summit Pharmaceuticals International investment in Series A - Luxna Biotech
Senshu Ikeda Capital
Senshu Ikeda Capital investment in Series A - Luxna Biotech
Mizuho Capital
Mizuho Capital investment in Series A - Luxna Biotech
Osaka University Venture Capital
Osaka University Venture Capital investment in Series A - Luxna Biotech
Nissan Chemical Industries
Nissan Chemical Industries investment in Series A - Luxna Biotech
Japan Finance
Japan Finance investment in Debt Financing - Luxna Biotech
Osaka University Venture Capital
Osaka University Venture Capital investment in Seed Round - Luxna Biotech
Official Site Inspections
http://www.luxnabiotech.co.jp
- Host name: www18.gmoserver.jp
- IP address: 133.130.64.112
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Luxna Biotech"
About - Luxna Biotech Co., Ltd.
Luxna Biotech Co., Ltd. Date founded December 18, 2017 Business 1. Collaborative Drug Discovery Program with Pharmaceutical Companies 2. XNAs Technology Licensing Business …See details»
Luxna Biotech - Crunchbase Company Profile & Funding
Organization. Luxna Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@luxnabiotech.co.jp; …See details»
Business Structure - Luxna Biotech Co., Ltd.
Business Structure. Pharmaceutical companies or academic groups (genetic diseases, immune diseases, neurological diseases, etc.) who are investigating treatments for target diseases …See details»
Luxna Biotech Company Profile 2024: Valuation, …
Luxna Biotech General Information Description. Operator of a biotechnology company intended to promote safe and effective oligonucleotide therapeutics. The company's drugs are based on a licensed cross-linked modified nucleic …See details»
Luxna Biotech Co., Ltd. - j-startup.go.jp
Luxna Biotech Co., Ltd. Medical Engineering & Biotechnology Corporate Number｜7120901039358. https://luxnabiotech.co.jp/ja/ Luxna Biotech is a preclinical stage …See details»
ルクサナバイオテク株式会社 - j-startup.go.jp
Https://luxnabiotech.co.jp/ja/ ルクサナバイオテクは、病気と闘う患者さんと支える方々を"照らす光"Lux"となる優れたアンチセンス医薬実用化を目指しております。See details»
Luxna Biotech | VentureRadar
Website: https://luxnabiotech.co.jp/ Develops antisense drug technologies utilizing novel modified nucleosides, collaborating with pharmaceutical companies and academic labs, focusing on …See details»
News - Luxna Biotech Co., Ltd.
We will exhibit at the Organization for Small & Medium Enterprises and Regional Innovation, Japan booth at “Bio Japan 2024”. 2024/10/07; Event; Read. ... MAIL: info@luxnabiotech.co.jp; …See details»
Luxna Biotech Co., Ltd. | J-Startup
Https://luxnabiotech.co.jp/ja/ Luxna Biotech is a preclinical stage antisense drug development company. Our technologies are consisted by novel modified nucleosides invented by Osaka University and original drug development …See details»
LUXNA BIOTECH CO., LTD. - Dun & Bradstreet
Luxna biotech co., ltd. d&b business directory home / business directory / professional, scientific, and technical services / other professional, scientific, and technical services / japan / osaka / …See details»
Notification for the determination of investment in share of Luxna ...
Please visit https://luxnabiotech.co.jp/en/ About Nissan Chemical Corporation Nissan Chemical Corporation is now moving forward to develop new products and businesses through …See details»
Luxna Biotech - Overview, News & Similar companies - ZoomInfo
Www.luxnabiotech.co.jp. Revenue $10.2 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview; Org Chart; Who is …See details»
【KANSAI to the World】#01 Luxana Biotech - en.kansai-startup ...
関西スタートアップエコシステムのポータルサイトです。Deeptech valley Kansaiの紹介を行っています。See details»
Luxna Announces Collaboration Agreement for Drug Discovery …
Osaka, Japan, April 6th, 2023 - Luxna Biotech Co., Ltd. (President & CEO: Hideaki Sato, Headquarters: Suita-shi, Osaka, Japan, hereinafter “Luxna”) today announced that it has …See details»
(Translation) - Renascience-レナサイエンス-
[Luxna Biotech Co., Ltd.] Luxna Biotech is a biotech company established to promote the practical application of safe and effective pharmaceuticals using a drug discovery platform for …See details»
Technology - Luxna Biotech Co., Ltd.
文献情報. AmNA ®. Yahara A1, Shrestha AR, Yamamoto T, Hari Y, Osawa T, Yamaguchi M, Nishida M, Kodama T, Obika S. Amido-bridged nucleic acids (AmNAs): synthesis ...See details»
Luxna Biotech - Craft
Luxna Biotech has 1 employees at their 1 location and $934.64 k in total funding,. See insights on Luxna Biotech including office locations, competitors, revenue, financials, executives, …See details»
ルクサナバイオテクとSPIによるルクサナバイオテクの人工修飾核 …
Dec 17, 2024 ルクサナバイオテク株式会社（代表取締役社長ceo：佐藤 秀昭、本社：大阪府吹田市、以下「ルクサナバイオテク」）と住商ファーマインターナショナル株式会社（代表取 …See details»
Luxna Biotech Co., Ltd. Luxna Biotech and Head Office for Open ...
Luxna Biotech Co., Ltd. Head Office for Open Innovation Business Development Strategy, Tohoku University Luxna Biotech and Head Office for Open Innovation Business Development …See details»
Luxna Announces Collaboration Agreement - luxnabiotech.co.jp
April 6th, 2023 Luxna Announces Collaboration Agreement for Drug Discovery Research with Servier Osaka, Japan, April 6th, 2023 - Luxna Biotech Co., Ltd. (President & CEO: Hideaki …See details»